Stock Market News 17 October 2025

Fraud Shocks at Regional Lenders Ignite a Selloff This week’s drama began when Zions Bancorporation, a Utah-based regional bank, revealed a major loan fraud that blindsided investors. In an SEC filing on Oct. 15, Zions said it discovered “misrepresentations and contractual defaults” in two large commercial loans (~$60 million total) made by its California Bank & Trust unitts2.tech. The borrowers – investment funds tied to financiers Andrew Stupin and Gerald Marcil – allegedly used the money to buy distressed mortgages, then shuffled the collateral to other entities, according to Zions’ lawsuit (the borrowers deny the allegations)straitstimes.comstraitstimes.com. Zions moved quickly: it accelerated

Fraud Bombshell Sends Zions Stock Reeling Zions Bancorp, a Salt Lake City-based regional bank, dropped a stunning disclosure this week: it found evidence of potential fraud in two large commercial loans worth about $60 million ts2.tech. The borrowers – reportedly affiliated with an independent investment fund – allegedly misrepresented collateral and other information, prompting Zions to accelerate the loans to default and sue the guarantors in California ts2.tech. The bank wrote off $50 million of the exposure and set aside reserves for the rest, effectively recognizing a full $60 million hit ts2.tech. This charge-off will flow through Zions’ upcoming earnings, immediately denting Q3

Market Selloff Deepens on Credit Fears A wave of credit-related jitters hit Wall Street, igniting a broad selloff led by financial stocks. On Thursday, the Dow, S&P 500, and Nasdaq all shed nearly 1% of their value ts2.tech. The selloff was concentrated in regional banks, where bad loan news triggered outsized damage. Zions Bancorp disclosed a surprise $50 million loan charge-off, sinking its stock by double-digits, while Western Alliance revealed it is suing a borrower over alleged fraud – news that sent its shares tumbling as well ts2.tech. Even Jefferies, an investment firm, saw its stock slide on concerns about

{“@context”:”https://schema.org”,”@type”:”LiveBlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-17-10-2025/#live”,”headline”:”Stock Market Today 17.10.2025″,”description”:”Live rolling coverage of stock markets, macro data, and major moves.”,”datePublished”:”2025-10-17T06:01:01-04:00″,”dateModified”:”2025-10-19T06:00:10-04:00″,”coverageStartTime”:”2025-10-17T06:01:01-04:00″,”coverageEndTime”:”2025-10-19T06:00:10-04:00″,”author”:{“@type”:”Organization”,”name”:”TechStock²”},”publisher”:{“@type”:”Organization”,”name”:”TechStock²”,”logo”:{“@type”:”ImageObject”,”url”:”https://ts2.tech/wp-content/uploads/2024/02/cropped-ts2-logo-google.png”}},”inLanguage”:”en-US”,”liveBlogUpdate”:[{“@type”:”BlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-17-10-2025/#live/u/554ef6f94eda71f5″,”headline”:”IndiGo Finalizes 30-Airbus A350 Order, Lifting Total A350 Commitments to 60″,”articleBody”:”IndiGo has firmed up a commitment for 30 Airbus A350s, converting a June MoU into a binding order and lifting its total A350 orders to 60. The deal underscores growing demand for widebodies as the carrier expands long-haul capacity. Airbus notes the A350 already supports up to 50% SAF use and aims to make all aircraft 100% SAF-capable by 2030. Globally, the A350 program has logged over 1,400 orders from 63 customers through September 2025, highlighting the

Trump’s Trade War Tantrum Shakes Markets After months of climbing to record highs, markets were blindsided in mid-October by an abrupt escalation in the U.S.–China trade conflict. On October 10, former President Donald Trump unleashed a “shock tariff ultimatum” via social media, vowing to slap 100% tariffs on all remaining Chinese imports and scrapping an upcoming peace summit with China’s President Xi reuters.com reuters.com. Beijing had moved to tighten exports of critical rare-earth minerals days prior, and Trump’s furious response signaled “Trade War 2.0” was on. The aggressive rhetoric stunned investors and “rattled markets”, erasing optimism that had driven stocks

Record Stock Surge on Phase 3 Breakthrough Praxis Precision Medicines shares skyrocketed on October 16, 2025, after the biotech reported game-changing Phase 3 trial results for its essential tremor drug. The stock closed that Thursday at $162.71, up over 183% in a single daymedcitynews.com. Earlier that morning, Praxis announced that ulixacaltamide – its experimental therapy for essential tremor – had succeeded in two pivotal late-stage studies. The news sent PRAX stock soaring more than threefold before the opening bellreuters.comreuters.com, smashing its previous highs. By midday, Reuters estimated Praxis was on track to add about $2.67 billion to its market capitalization if gains